Carrie Lachance Acquires 2,000 Shares of InfuSystem (NYSE:INFU) Stock

Posted by Stanley Muller on May 12th, 2026

InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) CEO Carrie Lachance bought 2,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.83 per share, with a total value of $17,660.00. Following the acquisition, the chief executive officer directly owned 237,123 shares in the company, valued at approximately $2,093,796.09. This trade represents a 0.85% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Carrie Lachance also recently made the following trade(s):

On Monday, May 11th, Carrie Lachance purchased 1,000 shares of InfuSystem stock. The stock was acquired at an average price of $8.46 per share, for a total transaction of $8,460.00.

InfuSystem Trading Down 2.5%

INFU stock traded down $0.21 during midday trading on Tuesday, reaching $8.16. 244,052 shares of the company’s stock traded hands, compared to its average volume of 135,464. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. InfuSystem Holdings, Inc. has a fifty-two week low of $5.08 and a fifty-two week high of $11.04. The business has a 50-day moving average price of $9.67 and a two-hundred day moving average price of $9.21. The company has a market capitalization of $164.76 million, a P/E ratio of 136.01 and a beta of 1.49.

Institutional Investors Weigh In On InfuSystem

Several hedge funds and other institutional investors have recently added to or reduced their stakes in INFU. Cubist Systematic Strategies LLC purchased a new position in InfuSystem in the 1st quarter valued at about $129,000. Jane Street Group LLC purchased a new position in InfuSystem in the first quarter valued at about $96,000. Acadian Asset Management LLC grew its stake in InfuSystem by 219.1% during the 1st quarter. Acadian Asset Management LLC now owns 39,117 shares of the company’s stock valued at $208,000 after purchasing an additional 26,860 shares in the last quarter. American Century Companies Inc. increased its holdings in InfuSystem by 147.4% during the 2nd quarter. American Century Companies Inc. now owns 117,812 shares of the company’s stock worth $735,000 after purchasing an additional 70,188 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of InfuSystem in the 2nd quarter valued at approximately $185,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Roth Mkm reaffirmed a “buy” rating and set a $15.00 price target (up from $14.00) on shares of InfuSystem in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.00.

View Our Latest Analysis on InfuSystem

About InfuSystem

(Get Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.